Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

508
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
508
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Variability: Analysis01:11

Variability: Analysis

126
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
126
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal function.

Annals of medicine·2026
Same author

Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM's Diabesity Day Survey 2024.

European journal of internal medicine·2025
Same author

Switch of Open-Source Automated Insulin Delivery (AID) System-AndroidAPS to Commercially Available AID Systems in Type 1 Diabetes: The Extension of the CODIAC Study.

Diabetes technology & therapeutics·2025
Same author

Blood pressure levels are higher in individuals with type 1 diabetes mellitus compared to healthy subjects during exercise stress test.

Scientific reports·2025
Same author

Comparison of the Aireen System with Telemedicine Evaluation by an Ophthalmologist - A Real-World Study.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

The Effect of Nutrition Education on Glycemic Outcomes in People With Type 1 Diabetes Initiating the Use of Glucose Sensors.

Endocrinology, diabetes & metabolism·2025

Related Experiment Video

Updated: Jun 8, 2025

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
10:39

Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

Published on: March 8, 2018

8.3K

Glucose variability and diabetic microvascular complications.

Martin Prázný, Jan Škrha, Jan Šoupal

    Casopis Lekaru Ceskych
    |November 8, 2024
    PubMed
    Summary

    Glucose variability, or fluctuations in blood sugar, may independently contribute to microvascular complications in diabetes. Further research is needed to understand its role in diabetic retinopathy, nephropathy, and neuropathy.

    Keywords:
    glucose variability, glycated hemoglobin HbA1c, microvascular complications, diabetes mellitus

    More Related Videos

    Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
    04:36

    Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

    Published on: January 12, 2024

    1.0K
    Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
    07:41

    Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

    Published on: October 23, 2020

    5.6K

    Related Experiment Videos

    Last Updated: Jun 8, 2025

    Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo
    10:39

    Laser Doppler: A Tool for Measuring Pancreatic Islet Microvascular Vasomotion In Vivo

    Published on: March 8, 2018

    8.3K
    Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
    04:36

    Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

    Published on: January 12, 2024

    1.0K
    Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
    07:41

    Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

    Published on: October 23, 2020

    5.6K

    Area of Science:

    • Endocrinology and Metabolism
    • Cardiovascular Research
    • Diabetology

    Background:

    • Inadequate long-term diabetes control, measured by glycated haemoglobin (HbA1c), is linked to microvascular complications.
    • Glucose fluctuations are associated with oxidative stress, endothelial dysfunction, and inflammation, contributing to vascular damage.
    • The role of glucose variability in microvascular disease remains debated, unlike its established link to macrovascular disease.

    Purpose of the Study:

    • To review existing research on glucose variability and its association with microvascular complications in diabetes.
    • To address the question of whether short-term glucose variability is an independent risk factor for these complications.
    • To highlight the need for further investigation into glucose variability parameters.

    Main Methods:

    • Literature review of studies examining glucose variability.
    • Analysis of research connecting glucose variability to diabetic retinopathy, nephropathy, and neuropathy.
    • Synthesis of current data on the impact of glucose fluctuations on microvascular health.

    Main Results:

    • Current data suggest a potential link between glucose variability and microvascular complications.
    • The independent contribution of short-term glucose variability requires further investigation.
    • Understanding variability parameters is crucial for risk assessment and treatment optimization.

    Conclusions:

    • Further research is essential to elucidate the precise role of both short-term and long-term glucose variability in diabetic microvascular complications.
    • Glucose variability parameters may prove valuable in tailoring treatment strategies and predicting the risk of chronic diabetic complications.
    • The findings underscore the importance of considering glucose fluctuations beyond average HbA1c levels for comprehensive diabetes management.